Lv1
60 积分 2025-10-10 加入
Talquetamab plus Teclistamab in Relapsed or Refractory Multiple Myeloma
11个月前
已完结
Spatial transcriptomics reveals profound subclonal heterogeneity and T-cell dysfunction in extramedullary myeloma
11个月前
已完结
Limited efficacy of daratumumab in multiple myeloma with extramedullary disease
11个月前
已完结
Natural history, predictors of development of extramedullary disease, and treatment outcomes for patients with extramedullary multiple myeloma
11个月前
已完结
皖公网安备34019202002308
